Trials / Conditions / Islet Cell Carcinoma
Islet Cell Carcinoma
6 registered clinical trials studyying Islet Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas NCT03042780 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Active Not Recruiting | Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors NCT01824875 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Completed | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemo NCT00363051 | Novartis Pharmaceuticals | Phase 2 |
| Completed | RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma NCT00113360 | M.D. Anderson Cancer Center | Phase 2 |
| Withdrawn | Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respon NCT00003514 | Burzynski Research Institute | Phase 2 |
| Withdrawn | Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors NCT00227773 | Eastern Cooperative Oncology Group | Phase 2 |